Viruses-Basel

Papers
(The H4-Index of Viruses-Basel is 69. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)
ArticleCitations
Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution471
COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention361
A Roadmap for Genome-Based Phage Taxonomy304
VIRIDIC—A Novel Tool to Calculate the Intergenomic Similarities of Prokaryote-Infecting Viruses297
Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms259
Domains and Functions of Spike Protein in SARS-Cov-2 in the Context of Vaccine Design231
The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation203
Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice185
Age-Dependent Progression of SARS-CoV-2 Infection in Syrian Hamsters181
Comparison of Rapid Antigen Tests for COVID-19167
Dengue: A Minireview158
Deploying Machine and Deep Learning Models for Efficient Data-Augmented Detection of COVID-19 Infections151
Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?148
Highly Pathogenic Avian Influenza Viruses at the Wild–Domestic Bird Interface in Europe: Future Directions for Research and Surveillance142
Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection136
Mutations and Evolution of the SARS-CoV-2 Spike Protein135
Herpes zoster: A Review of Clinical Manifestations and Management135
Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease130
Attitudes towards Anti-SARS-CoV2 Vaccination among Healthcare Workers: Results from a National Survey in Italy130
Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech)128
SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-β Production123
Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19122
Tracking SARS-CoV-2 in Sewage: Evidence of Changes in Virus Variant Predominance during COVID-19 Pandemic121
Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2121
Heat Inactivation of Different Types of SARS-CoV-2 Samples: What Protocols for Biosafety, Molecular Detection and Serological Diagnostics?120
A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies119
The Advantages and Challenges of Using Endolysins in a Clinical Setting114
Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro113
Curcumin as an Antiviral Agent113
Here, There, and Everywhere: The Wide Host Range and Geographic Distribution of Zoonotic Orthopoxviruses110
Placental Pathology of COVID-19 with and without Fetal and Neonatal Infection: Trophoblast Necrosis and Chronic Histiocytic Intervillositis as Risk Factors for Transplacental Transmission of SARS-CoV-110
SARS-CoV-2 Infections and Viral Isolations among Serially Tested Cats and Dogs in Households with Infected Owners in Texas, USA110
Silencing and Transcriptional Regulation of Endogenous Retroviruses: An Overview108
Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications104
Long-COVID Symptoms in Individuals Infected with Different SARS-CoV-2 Variants of Concern: A Systematic Review of the Literature98
Neutralizing Antibody Therapeutics for COVID-1997
The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner96
The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies93
Dance with the Devil: Stress Granules and Signaling in Antiviral Responses93
The Spike of Concern—The Novel Variants of SARS-CoV-293
Broad-Spectrum Antiviral Strategies and Nucleoside Analogues91
African Swine Fever in Wild Boar in Europe—A Review89
Lentiviral Vector Bioprocessing88
Coronavirus Infections in Companion Animals: Virology, Epidemiology, Clinical and Pathologic Features87
Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak87
Aphid Transmission of Potyvirus: The Largest Plant-Infecting RNA Virus Genus86
A Comparison of Whole Genome Sequencing of SARS-CoV-2 Using Amplicon-Based Sequencing, Random Hexamers, and Bait Capture86
The Mechanism behind Influenza Virus Cytokine Storm85
Persistent Human Papillomavirus Infection84
Liquid Biomolecular Condensates and Viral Lifecycles: Review and Perspectives84
SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations82
Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation81
SARS-CoV-2, CT-Values, and Infectivity—Conclusions to Be Drawn from Side Observations81
Natural and Experimental SARS-CoV-2 Infection in Domestic and Wild Animals79
Inactivation of Human Coronavirus by Titania Nanoparticle Coatings and UVC Radiation: Throwing Light on SARS-CoV-278
Antiviral Activity Exerted by Natural Products against Human Viruses78
The Spread of SARS-CoV-2 Variant Omicron with a Doubling Time of 2.0–3.3 Days Can Be Explained by Immune Evasion76
SARS-CoV-2 Survival on Surfaces and the Effect of UV-C Light76
SARS-CoV-2 RNA Extraction Using Magnetic Beads for Rapid Large-Scale Testing by RT-qPCR and RT-LAMP75
Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML18875
Recombination in Coronaviruses, with a Focus on SARS-CoV-275
Mutation Rates, Mutation Frequencies, and Proofreading-Repair Activities in RNA Virus Genetics74
Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b273
Biological and Clinical Consequences of Integrin Binding via a Rogue RGD Motif in the SARS CoV-2 Spike Protein73
Monkeypox: A Comprehensive Review71
Regulation of KSHV Latency and Lytic Reactivation71
Current Developments and Challenges in Plant Viral Diagnostics: A Systematic Review71
A Case of Phage Therapy against Pandrug-Resistant Achromobacter xylosoxidans in a 12-Year-Old Lung-Transplanted Cystic Fibrosis Patient70
Neuroinvasion and Neurotropism by SARS-CoV-2 Variants in the K18-hACE2 Mouse69
ABO Blood Types and COVID-19: Spurious, Anecdotal, or Truly Important Relationships? A Reasoned Review of Available Data69
Clinical Update of Severe Fever with Thrombocytopenia Syndrome69
0.045480966567993